A multicenter cohort study of dose-dense temozolomide (21 of 28 days) for the treatment of recurrent anaplastic astrocytoma or oligoastrocytoma.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples